HomeXVIPF • OTCMKTS
add
Xvivo Perfusion AB
Previous close
$39.00
Year range
$25.37 - $52.38
Market cap
14.68B SEK
Avg Volume
41.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 227.56M | 46.12% |
Operating expense | 139.60M | 5.64% |
Net income | 36.39M | -46.86% |
Net profit margin | 15.99 | -63.63% |
Earnings per share | 1.64 | -39.55% |
EBITDA | 47.08M | 2,895.96% |
Effective tax rate | 26.66% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 415.52M | -23.91% |
Total assets | 2.40B | 9.43% |
Total liabilities | 245.96M | -1.84% |
Total equity | 2.16B | — |
Shares outstanding | 31.50M | — |
Price to book | 0.57 | — |
Return on assets | 3.80% | — |
Return on capital | 4.13% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 36.39M | -46.86% |
Cash from operations | 62.08M | 242.49% |
Cash from investing | -111.40M | -111.84% |
Cash from financing | -2.39M | 35.75% |
Net change in cash | -34.46M | 28.46% |
Free cash flow | 44.73M | 190.71% |
About
Founded
1998
Website
Employees
170
